32 results
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
of operations, business strategy, and financial needs. In light of the significant uncertainties in these forward-looking statements, you should not rely upon … , and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
, and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy … and financial trends that we believe may affect our financial condition, results of operations, business strategy, and financial needs. In light
424B4
CGTX
Cognition Therapeutics Inc
8 Jan 24
Prospectus supplement with pricing info
4:11pm
of operations, business strategy, and financial needs. In light of the significant uncertainties in these forward-looking statements, you should not rely upon
8-K
EX-99.1
mcnu u1a3p95gl61
12 Sep 23
Other Events
7:00am
8-K
EX-99.1
japvkp wfhnuh8
24 Aug 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
08csuc881k8ek neir52
4 May 23
Cognition Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:06pm
S-3
77p35pf25
23 Dec 22
Shelf registration
4:16pm
424B4
e93j0gaudmm1soo30vb
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
x1z ju4txq
20 Oct 22
Draft registration statement
12:00am